Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 69.5	$ 62.0
Accounts receivable, net	40.2	31.6
Inventories	22.5	17.3
Income tax receivable	11.1	0.9
Prepaid expenses and other current assets	9.7	13.1
Total current assets	153.0	124.9
Property, plant and equipment, net	143.9	142.1
Operating lease right-of-use assets, net	22.2	23.7
Goodwill	451.3	450.1
Intangible assets, net	324.4	345.4
Deferred tax assets	0.1	0.1
Other assets	38.4	36.4
Total assets	1,133.3	1,122.7
Current liabilities
Accounts payable	24.4	17.6
Accrued liabilities and other	28.9	22.1
Current portion of long-term debt	2.7	2.5
Operating lease liabilities, current	4.0	3.8
Deferred revenue	4.8	2.0
Total current liabilities	64.8	48.0
Long-term debt	400.5	397.8
Deferred tax liabilities	71.2	71.6
Derivative instruments	7.4	6.3
Operating lease liabilities, non-current	22.3	24.7
Other liabilities	2.8	2.3
Total liabilities	569.0	550.7
Commitments and contingencies – Note 13
Shareholders’ equity
Additional paid-in capital	697.9	693.7
Accumulated deficit	(134.5)	(123.8)
Accumulated other comprehensive income	0.9	2.1
Total shareholders’ equity	564.3	572.0
Total liabilities and shareholders’ equity	1,133.3	1,122.7
Class A common stock, $0.0001 par, 200,000,000 shares authorized at September 30, 2024 and December 31, 2023 Shares issued and outstanding: 80,309,764 and 79,684,170 at September 30, 2024 and December 31, 2023, respectively
Shareholders’ equity
Common stock	0.0	0.0
Convertible Class C common stock, $0.0001 par, 200,000,000 shares authorized at September 30, 2024 and December 31, 2023 Shares issued and outstanding: 2,921,099 at September 30, 2024 and December 31, 2023
Shareholders’ equity
Common stock	$ 0.0	$ 0.0